News – Page 69 – Endpoints News

Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinic

5 months ago

Exclusive: Bain-backed musculoskeletal biotech raises $120M for trio of clinical-stage biologics

5 months ago

Exclusive: Negev Labs unveils with $30M in assets, striving to build a network of psychedelic biotechs

5 months ago

Bayer exits Europe pact with Moberg for nail fungus drug after Phase 3 fail

5 months ago

Contending with Americans’ fury at health insurers

5 months ago

Early data on BTK degraders suggest promise of next-gen approach

5 months ago

NewAmsterdam hits primary endpoint in latest Phase 3 trial of CETP inhibitor

5 months ago

UniQure stock doubles on FDA 'alignment' over accelerated approval for Huntington's drug

5 months ago

Exclusive: Two Vida Ventures co-founders exit the VC firm

5 months ago

Walgreens in talks to sell to private equity — report

6 months ago

Cases of severe RSV in two Moderna vaccine candidates' trials raise questions about future

6 months ago

J&J, Legend’s Carvykti clears a type of blood cancer in ‘nine out of 10’ patients

6 months ago

Cardiff unveils positive Phase 2 data for colorectal cancer drug, $40M offering

6 months ago

Halia Therapeutics takes NLRP3 inhibitor into final stage of Phase 2 trial

6 months ago

Early data suggest Arvinas, Pfizer could combine their breast cancer drug with Lilly’s Verzenio

6 months ago

CervoMed’s Phase 2 miss; NICE to cover Santhera’s Duchenne drug

6 months ago

Roche initially didn't want to buy Poseida — and partner Astellas didn't submit an offer, new filings show

6 months ago

BioNTech reports early survival data for VEGF bispecific, weeks after buying Chinese partner

6 months ago

Olema Oncology makes case for its oral SERD with fresh data cut from early breast cancer trial

6 months ago

New oncology biotech launches with $52M in its pocket

6 months ago

BTK inhibitors from AstraZeneca, Eli Lilly and BeiGene take center stage in CLL

6 months ago

Arcellx and Gilead seek to unseat Legend and J&J with multiple myeloma cell therapy

6 months ago

Kura Oncology details 'aggressive' approach in first-line AML

6 months ago

Retrospective analysis shows potential for GLP-1s to treat blood clots

6 months ago

First page Previous page 66 67 686970 71 72 Next page Last page